CDE accepts the application for consistency evaluation of phenobarbital tablets
Good news keeps coming. In May 2021, CDE accepted our company's application for consistency...
CDE accepts the application for registration and listing of Apixaban tablets
On April 29, 2021, our company's generic drug marketing authorization application for Apixaban tablets
The factory has passed GMP certification
On February 2, 2019, Shanghai Ideal Pharmaceutical Co., Ltd. successfully obtained the "Drug GMP Certificate". Since the acquisition of Ideal Pharmaceutical in 2015, after...
Phenobarbital Tablets Got Relocation Approval
On August 27, 2018, the Shanghai Food and Drug Administration approved the application for the relocation of ...
Obtained Drug Manufacturing License
China Crown Pharmaceutical Ltd submitted the GMP application to Shanghai Food and Drug Administration on June 16, 2017 (file no. : AJ170429)...